Learn
Explore our list of resources
Depending on your rare disease journey, Global Genes provides you with the resource and community to enhance your learning.
Featured
Gene-Based Diagnosis 101: How to Successfully Navigate the Diagnostic Journey
As scientific innovation in genomic medicine continues to provide more hope for therapeutic options, there is a […]
Read moreA Case for Whole Genome Sequencing
The ability to diagnose rare genetic diseases through the use of genetic sequencing has improved to a […]
Read moreAdvances in Rare Immunological Diseases
Recent advances in rare immunological diseases have raised the exciting potential of cures for some disorders. Hear […]
Read moreDevelopmental Delays After Factor V Leiden Pregnancy
by Tiffany Burnette I was diagnosed with Factor V Leiden when I was pregnant with Sammy. While […]
Read morePatient Stories
Living and Advocating Through a Complex Medical Journey: Erythromelalgia, Visual Snow Syndrome, and Autoimmune Dysregulation
Hello, my name is Sierra Domb. Since childhood, I have experienced Erythromelalgia (EM) and Autoimmune Dysregulation (AD). […]
Read moreLiving with Brugada Syndrome
Brugada is insidious, especially for someone my age. It tends to “hide” in the ECG. Many times, it looks normal… but it isn’t. And with the myocarditis I had at the same time, it was even harder to get a correct diagnosis. The doctors didn’t know whether the findings were due to Brugada or to myocarditis. After my hospitalization, and after I suffered a fainting episode, it was finally decided that I should be implanted with a defibrillator (ICD). When it happened, I felt like life was given back to me.
Read moreHe Is Three. His Voice Isn’t Lost —It’s Waiting to Be Heard.
By the time a genetic diagnosis of a rare mutation in the PPP3CA gene finally arrived, critical months — even years — had slipped away. Milestones were missed while we waited for answers. Early concerns were minimized, and our pleas for help were too often brushed aside until delays became severe. That delay is not just a bureaucratic failure; it is lost opportunity — lost time for therapies that could have helped him build strength, communication, and independence.
Read moreThe Beginning of Our Lowe Syndrome Journey
By Caroline Tsai The sun blazes overhead without a cloud in sight. Only a high of 90 […]
Read moreInvincible Never Invisible: A Decade of InvisiYouth
I was competitive tennis player as a teen and was unfortunately injured in training, which resulted in dealing with an injury and neurovascular condition that changed the trajectory of my life. I was thrust into the world of living with a chronic illness, years of trying to find proper diagnoses and treatments, all while balancing life as a teen/young adult. During this entire young adult experience, my doctors would tell me “wait” till they could fix my health to live my life fully… I created InvisiYouth out of my love of philanthropy, and my newfound passion to giving a voice for the young adult population living with all chronic illnesses and disabilities for the non-medical aspects of their lives with health struggles.
Read moreBeauty in Being Rare
Classical HCU is a condition in which my liver has a defective enzyme that is supposed to break down methionine. Instead, it builds up and turns into homocysteine, which is extremely toxic to your body. These elevated levels can result in blood clots, strokes, and other life-threatening complications. I follow an extremely restrictive low-protein diet—only about 10 grams of whole protein per day—alongside a methionine-free formula, the medication called betaine, and a cocktail of vitamins and supplements.
Read moreLatest News
Savara’s Early Access Program
Savara’s Early Access Program (EAP) for molgramostim inhalation solution (molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune […]
Read morePublication Announcement — RARE-X: Advancing Rare Disease Research Through Patient-Driven Data
Global Genes is excited to announce “RARE-X: A patient-driven approach for collecting symptom and patient-reported outcome data […]
Read moreAccelerating Rare Disease Research Through Collaboration: Global Genes and Notre Dame Launch the Research Acceleration Program
Global Genes and University of Notre Dame have partnered to launch the Research Acceleration Program, a collaborative […]
Read moreRARE Advocacy Exchange Session 8, Knowing Your Rare Rights
This session recording is from Oct. 16, 2025 Rare Advocacy Exchange Session 8: Knowing the Rights for […]
Read moreGlobal Genes Guide to Starting a Nonprofit Patient Advocacy Organization
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 7, Getting a Precise Genetic Diagnosis
This session recording is from Sept. 18, 2025 Rare Advocacy Exchange Session 7: Getting A Precise Diagnosis […]
Read moreIndustry News
Atavistik Bio Adds $40 Million to Series B to Advance HHT and MPN Programs
Rare Daily Staff Atavistik Bio said it raised an additional $40 million in an extension of its […]
Read moreReopening the Developmental Window in Rett Syndrome with a Gene Therapy
Rett syndrome is a rare neurodevelopmental disorder that disrupts a child’s ability to purposely use their hands, […]
Read moreAntiverse Raises $9.3 Million, Enters Research Agreement with Cystic Fibrosis Foundation
Rare Daily Staff Antiverse, a biotech using artificial intelligence to design antibodies for traditionally “undruggable” targets, has […]
Read moreFDA Wants Additional Study from UniQure for Huntington’s Disease Gene Therapy
Rare Daily Staff The U.S. Food and Drug Administration advised gene therapy developer UniQure to run an […]
Read moreFDA Lifts Hold on Intellia’s Experimental Gene-Editing Therapy for ATTR-CM
Rare Daily Staff The U.S. Food and Drug Administration has removed a clinical hold on Intellia Therapeutics’ […]
Read moreFDA Grants Ascendis Accelerated Approval for Achondroplasia Drug
Rare Daily Staff The U.S. Food and Drug Administration has granted accelerated approval to Ascendis Pharma’s Yuviwel, […]
Read moreFDA Expands Use of BioMarin PKU Drug
Rare Daily Staff The U.S. Food and Drug Administration has granted expanded approval to BioMarin Pharmaceutical for […]
Read moreAvidity Spinout Launches with $270 Million, Focus on Rare Cardiomyopathies
Rare Daily Staff Atrium Therapeutics, a spinout from Avidity Biosciences, has launched as a newly independent, publicly […]
Read moreARPA-H to Provide Every Cure up to $76 Million for AI-Drive Drug Repurposing
Rare Daily Staff The Advanced Research Projects Agency for Health (ARPA-H) will provide up to $76 million […]
Read moreGenetic Counseling
Global Genes Guide to Genetic Diagnosis
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes 2025 Quick Guide Series
We are excited to announce the launch of a new series of Quick Guides for the […]
Read moreAngelina Spreading Light, Love, and Inspiration on CASK Gene Awareness Day
To recognize CASK Gene Awareness Day on July 15, Global Genes reached out to Giovi Moschoudis, mother […]
Read moreTeam Wally Inspires During Fragile X Awareness Month
To recognize Fragile X Awareness Month in July, Global Genes reached out to National Fragile X Foundation, […]
Read moreFrom First Symptoms to Advocate for Transverse Myelitis
To recognize Transverse Myelitis Awareness Month in June, Global Genes reached out to The MOG Project, a […]
Read moreMoving from Awareness to Action after Sickle Cell Disease Diagnosis
Karen L. Proudford, Ph.D. is the President of Williams E. Proudford Sickle Cell Fund, Inc., and daughter […]
Read moreResearch Readiness
UC Berkeley Partners with BioMarin to Accelerate Rare Disease Research
The UC Berkeley Molecular Therapeutics Initiative (MTI) has entered into a new research collaboration with BioMarin Pharmaceutical […]
Read moreOxford-Harrington Awards Nearly $900K in Friedreich’s Ataxia Grants
Rare Daily Staff The Oxford-Harrington Rare Disease Centre’s FA Alliance Innovation Fund has awarded funding to five […]
Read moreKingsmore Stepping Down from Rady Children’s Institute for Genomic Medicine
Rare Daily Staff Stephen Kingsmore, a pioneer in the clinical use of rapid whole genome sequencing, will […]
Read moreA Gene Editing Approach to Work Across Multiple Diseases
Rare Daily Staff Researchers at the Broad Institute have developed a new genome-editing strategy that could potentially […]
Read moreNIH Makes $14.4 Million Award to Launch Initiative to Bring WGS to Newborn Screening
NIH Makes $14.4 Million Award to Launch Initiative to Bring WGS to Newborn Screening Rare Daily Staff […]
Read moreNIH awards Baylor $15.6 million to fund two rare diseases consortia
NIH awards Baylor $15.6 Million to Fund Two Rare Diseases Consortia Rare Daily Staff The National Institutes […]
Read moreMental Health & Wellness
RARE Advocacy Exchange Session 6 : Grieving a RARE Diagnosis
Rare disease grief differs from the grief we commonly associate with losing a loved one to death. […]
Read moreA Student’s Perspective: Lessons from the 2025 RARE Drug Development Symposium
During my first week as a Harvard College junior, I was delighted to be given the opportunity […]
Read moreGlobal Genes Guide to Securing a State Proclamation for Rare Disease Awareness
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Your Rare Rights
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Fundraising
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Comprehensive Fundraising Strategic Documents
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 5 : Interacting with FDA: PFDD and Listening Sessions
If your rare disease is likely to have a clinical trial for a drug or treatment come […]
Read moreA PAG Leader Guide to Presenting the Patient Experience at Your EL-PFDD Session with the FDA.
A Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreLove, Advocacy, and Belonging: Reflections from a Rare Disease Ally
By Nicole Boice, Chief Mission Officer, Global Genes As Chief Mission Officer at Global Genes—and as the […]
Read moreRARE Daily
A Data Strategy to Capitalize on a Multi‑Trillion Dollar Opportunity
A Data Strategy to Capitalize on a Multi‑Trillion Dollar Opportunity Rare diseases are often thought about in […]
Read moreCyprium to Sell PRV for $205 Million
Rare Daily Staff Cyprium Therapeutics, a majority-owned subsidiary of Fortress Biotech, agreed to sell its Rare Pediatric […]
Read moreFDA Grants Tessera Fast Track, Orphan Drug Designations for AATD Gene Writing Therapy
Rare Daily Staff The U.S. Food and Drug Administration granted Tessera Therapeutics Fast Track and Orphan Drug […]
Read moreFDA Unveils Framework to Speed Up Personalized Therapies for Ultra-Rare Diseases
Rare Daily Staff The U.S. Food and Drug Administration on Monday released draft guidance outlining a new regulatory framework […]
Read moreWhen a Gene Echoes Through a Family
A single genetic diagnosis can ripple through generations and reshape medical care for an entire family. Cascade […]
Read moreCervoMed’s Experimental Drug Selected for UK Platform Trial
Rare Daily Staff CervoMed said its lead experimental candidate, neflamapimod, has been selected for inclusion in the […]
Read moreSearch the RARE List
For more resources, disease-specific information, and news, search our RARE List- an extensive list of rare diseases and rare conditions.
Search Our Full RARE List